High Prevalence of Morphometric Vertebral Fractures Opportunistically Detected on Thoracic Radiograms in Patients with Non-functioning Pituitary Adenoma

Overview

Journal Pituitary

Specialty Endocrinology

Date 2024 May 27

PMID 38802688

Authors

Stefano Frara

Meliha Melin Uygur

Filippo Bolamperti

Luigi Di Filippo

Mauro Doga

Francesca Ferrari

Marco Losa

Pietro Mortini

Andrea Giustina

Affiliations

Soon will be listed here.

Abstract

Purpose: Vertebral fractures (VFs), the hallmark of skeletal fragility, have been reported as an emerging complication in patients with pituitary diseases associated with hormonal excess and/or deficiency, independently from bone mineral density. Non-functioning pituitary adenoma (NFPA) is amongst the most frequent pituitary adenomas; however, skeletal health in this context has never been investigated. We aimed at assessing the prevalence and the determinants of morphometric VFs in patients with NFPA.

Methods: We enrolled 156 patients (79 M/77F, mean age 55.75 ± 12.94 years) at admission in Neurosurgery Unit before trans-sphenoidal surgery and compared them with an age and sex-matched control group of subjects with neither history/risk factors for secondary osteoporosis nor pituitary disorders. We performed a vertebral morphometric evaluation of the thoracic spine on pre-operative X-ray images (MTRx) and collected biochemical, demographic, and clinical data from the entire cohort.

Results: The prevalence of thoracic VFs in patients with NFPA was significantly higher than the control group (26.3% vs. 10.3%; p < 0.001). In the NFPA group, 20 patients (48.8% of the fractured patients) showed multiple VFs, 14 (34.1% of them) showed moderate/severe VFs. Patients with VFs were significantly older and had lower serum free triiodothyronine (fT3) levels than non-fractured ones (p = 0.002 and p = 0.004; respectively). The prevalence of secondary male hypogonadism was higher among men with VFs as compared to those with no VFs (72% vs. 48.1%; p = 0.047). Consistently, total testosterone levels in males were significantly lower in fractured patients than in non-fractured ones (p = 0.02). The prevalence of gonadotroph adenomas was significantly higher among patients with VFs (p = 0.02). In multiple logistic regression analysis, older age and lower serum fT3 levels were independent factors predicting the risk for VFs.

Conclusions: For the first time, we reported a high prevalence of thoracic radiological VFs in patients with NFPAs. Our data should prompt clinicians to proceed with a clinical bone fragility evaluation already during the diagnostic work-up, particularly in those with concomitant hypogonadism, or in those with older age and/or with lower fT3.

Citing Articles

TSH-secreting pituitary adenomas and bone.

Losa M, Vassallo A, Frara S, Mortini P, Giustina A Pituitary. 2024; 27(6):752-760.

PMID: 39476262 DOI: 10.1007/s11102-024-01467-z.

Vitamin D and hip protectors in osteosarcopenia: a combined hip fracture preventing approach.

Giustina A, Giustina A Rev Endocr Metab Disord. 2024; 26(1):1-18.

PMID: 39352578 PMC: 11790758. DOI: 10.1007/s11154-024-09907-8.

Skeletal fragility in pituitary disease: how can we predict fracture risk?.

Bioletto F, Berton A, Barale M, Aversa L, Sauro L, Presti M Pituitary. 2024; 27(6):789-801.

PMID: 39240510 PMC: 11631825. DOI: 10.1007/s11102-024-01447-3.

References

Mortini P, Barzaghi L, Albano L, Panni P, Losa M . Microsurgical therapy of pituitary adenomas. Endocrine. 2017; 59(1):72-81. DOI: 10.1007/s12020-017-1458-3. View

Uygur M, Frara S, Di Filippo L, Giustina A . New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab. 2023; 34(4):231-242. DOI: 10.1016/j.tem.2023.01.006. View

Couselo M, Frara S, Giustina A, Casanueva F . Pituitary tumor centers of excellence for Cushing's disease. Pituitary. 2022; 25(5):772-775. PMC: 9587956. DOI: 10.1007/s11102-022-01264-6. View

Mazziotti G, Bianchi A, Bonadonna S, Nuzzo M, Cimino V, Fusco A . Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J Bone Miner Res. 2006; 21(4):520-8. DOI: 10.1359/jbmr.060112. View

Mazziotti G, Porcelli T, Bianchi A, Cimino V, Patelli I, Mejia C . Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. Eur J Endocrinol. 2010; 163(1):15-20. DOI: 10.1530/EJE-10-0125. View

Mazziotti G, Mormando M, Cristiano A, Bianchi A, Porcelli T, Giampietro A . Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism. Eur J Endocrinol. 2014; 170(6):893-9. DOI: 10.1530/EJE-14-0097. View

Mazziotti G, Frara S, Giustina A . Pituitary Diseases and Bone. Endocr Rev. 2018; 39(4):440-488. DOI: 10.1210/er.2018-00005. View

Mazziotti G, Doga M, Frara S, Maffezzoni F, Porcelli T, Cerri L . Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine. 2015; 52(1):103-10. DOI: 10.1007/s12020-015-0738-z. View

Frara S, Uygur M, Di Filippo L, Doga M, Losa M, Santoro S . High Prevalence of Vertebral Fractures Associated With Preoperative GH Levels in Patients With Recent Diagnosis of Acromegaly. J Clin Endocrinol Metab. 2022; 107(7):e2843-e2850. DOI: 10.1210/clinem/dgac183. View

10.

Mazziotti G, Canalis E, Giustina A . Drug-induced osteoporosis: mechanisms and clinical implications. Am J Med. 2010; 123(10):877-84. DOI: 10.1016/j.amjmed.2010.02.028. View

11.

Bornstein S, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer G . Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(2):364-89. PMC: 4880116. DOI: 10.1210/jc.2015-1710. View

12.

Mulhall J, Trost L, Brannigan R, Kurtz E, Redmon J, Chiles K . Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018; 200(2):423-432. DOI: 10.1016/j.juro.2018.03.115. View

13.

Petersenn S, Fleseriu M, Casanueva F, Giustina A, Biermasz N, Biller B . Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023; 19(12):722-740. DOI: 10.1038/s41574-023-00886-5. View

14.

Doga M, Bonadonna S, Gola M, Mazziotti G, Giustina A . Growth hormone deficiency in the adult. Pituitary. 2006; 9(4):305-11. DOI: 10.1007/s11102-006-0410-y. View

15.

Giustina A, Barkan A, Chanson P, Grossman A, Hoffman A, Ghigo E . Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults. J Endocrinol Invest. 2008; 31(9):820-38. DOI: 10.1007/BF03349263. View

16.

Yuen K, Biller B, Radovick S, Carmichael J, Jasim S, Pantalone K . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE. Endocr Pract. 2019; 25(11):1191-1232. DOI: 10.4158/GL-2019-0405. View

17.

Rossini M, Adami S, Bertoldo F, Diacinti D, Gatti D, Giannini S . Guidelines for the diagnosis, prevention and management of osteoporosis. Reumatismo. 2016; 68(1):1-39. DOI: 10.4081/reumatismo.2016.870. View

18.

Genant H, Wu C, van Kuijk C, Nevitt M . Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993; 8(9):1137-48. DOI: 10.1002/jbmr.5650080915. View

19.

Faggiano A, Pivonello R, Filippella M, Di Somma C, Orio Jr F, Lombard G . Spine abnormalities and damage in patients cured from Cushing's disease. Pituitary. 2002; 4(3):153-61. DOI: 10.1023/a:1015362822901. View

20.

Frara S, Losa M, Doga M, Formenti A, Mortini P, Mazziotti G . High Prevalence of Radiological Vertebral Fractures in Patients With TSH-Secreting Pituitary Adenoma. J Endocr Soc. 2018; 2(9):1089-1099. PMC: 6125713. DOI: 10.1210/js.2018-00091. View